Effect of Yoga-Diet therapy on weight management, menstrual, hormonal parameters and Quality of Life in Women with ovary cyst: A Randomized Controlled Trial

Not yet recruiting

Conditions: Obesity due to excess calories,

Registration Number: CTRI/2025/04/084920

Lead Sponsor: G KALEESWARI

Brief Summary: The study is a randomized, single blind, parallel group trail to assess the impact of Yoga diet synergy among women with Poly cystic ovary syndrome. The intervention is planned for 12 weeks for study group participants along with conventional treatment, whereas control group will receive only conventional treatment without structured yoga diet module. The primary outcome measures BMI, WHR, Menstrual parameters like duration, frequency of menstruation and dysmenorrhea, Quality of life of women which will be assessed after 36th day, 72nd day and 108th day of pretest. The secondary outcome will be measuring Hirsutism , Hormonal profile such as Testosterone, FSH, LH ,FSH LH ratio, prolactin which will be measured after 108 days of pretest. In addition to this clinical variables such as blood sugar, BP, USG Findings will be assessed.

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: Female

Target Recruitment: 228

Inclusion Criteria

Women who are Newly diagnosed with PCOS Age between 18 to 35 Years Both married and unmarried women Overweight and Obese (BMI more than 23) Not on any weight management or Yoga therapies other than allopathy medicine.

Exclusion Criteria

Women who are Pregnant Lactating woman Any other illness including reproductive illness which alters reproductive hormones and menstrual cycle and affecting ovulation or cause hyperandrogenemia hyperprolactenaemia androgen secreting ovarian or adrenal tumors hypothyroidism cushings syndrome acromegaly based on history recorded by obstrician Placed Intra uterine devices Physical limitations to perform yoga.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BMI	Baseline \| at 4 weeks \| at 8 weeks \| at 12 weeks
WHR	Baseline \| at 4 weeks \| at 8 weeks \| at 12 weeks
Menstrual parameters	Baseline \| at 4 weeks \| at 8 weeks \| at 12 weeks
Quality of life	Baseline \| at 4 weeks \| at 8 weeks \| at 12 weeks

Secondary Outcome Measures

Name	Time	Method
Hirsutism Ferrimen gallwey score	Hormonal profile such as Testosterone

Trial Locations

Locations (1): All India Institute of Medical Sciences
🇮🇳
Guntur, ANDHRA PRADESH, India
All India Institute of Medical Sciences
🇮🇳Guntur, ANDHRA PRADESH, India
Dr Sharmila
Principal investigator
9843776367
sharmila.obg@aiimsmangalagiri.edu.in